Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
Flaxman A, Sebastian S, Appelberg S, Cha KM, Ulaszewska M, Purushotham J, Gilbride C, Sharpe H, Spencer AJ, Bibi S, Wright D, Schmidt I, Dowall S, Easterbrook L, Findlay-Wilson S, Gilbert S, Mirazimi A, Lambe T. Flaxman A, et al. Among authors: sebastian s. PLoS Pathog. 2024 Jun 26;20(6):e1012262. doi: 10.1371/journal.ppat.1012262. eCollection 2024 Jun. PLoS Pathog. 2024. PMID: 38924060 Free PMC article.
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.
Bissett C, Belij-Rammerstorfer S, Ulaszewska M, Smith H, Kailath R, Morris S, Powers C, Sebastian S, Sharpe HR, Allen ER, Wang Z, Cunliffe RF, Sallah HJ, Spencer AJ, Gilbert S, Tregoning JS, Lambe T. Bissett C, et al. Among authors: sebastian s. NPJ Vaccines. 2024 Jun 26;9(1):118. doi: 10.1038/s41541-024-00912-1. NPJ Vaccines. 2024. PMID: 38926455 Free PMC article.
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Cargill T, Cicconi P, Brown A, Holland L, Karanth B, Rutkowski K, Ashwin E, Mehta R, Chinnakannan S, Sebastian S, Bussey L, Sorensen H, Klenerman P, Evans T, Barnes E. Cargill T, et al. Among authors: sebastian s. JHEP Rep. 2023 Aug 18;5(11):100885. doi: 10.1016/j.jhepr.2023.100885. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37791379 Free PMC article.
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV.
Davis C, Singh D, Anderson K, Vardeu A, Kopycinski J, Bridges-Webb A, Trickett A, O'Brien S, Downs M, Kaur R, Kolenovska R, Bussey L, Rutkowski K, Sebastian S, Cargill T, Barnes E, Evans TG, Cicconi P. Davis C, et al. Among authors: sebastian s. Vaccines (Basel). 2024 Jun 9;12(6):644. doi: 10.3390/vaccines12060644. Vaccines (Basel). 2024. PMID: 38932373 Free PMC article.
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial.
Borys D, Smulders R, Haranaka M, Nakano T, Chichili GR, Ebara M, Hashimoto A, Iwahana M, Oizumi Y, Nanra J, Malley R, Sebastian S. Borys D, et al. Among authors: sebastian s. Vaccine. 2024 Nov 28;44:126545. doi: 10.1016/j.vaccine.2024.126545. Online ahead of print. Vaccine. 2024. PMID: 39612802
Navigating mesenteric vasculitis: A comprehensive review of literature.
Zulfiqar F, Bilal M, Shah Y, Morgan S, Fatima R, Singh B, Sebastian SA, Roumia B, Bhatt P, Thallapally VK, Krishnamoorthy G, Hussain SAM. Zulfiqar F, et al. Among authors: sebastian sa. Dis Mon. 2024 Nov 25:101830. doi: 10.1016/j.disamonth.2024.101830. Online ahead of print. Dis Mon. 2024. PMID: 39592294
693 results